London, UK – 1 January 2026 – Avigen Ltd (“the Company”), a privately held Contract Research Organisation developing advanced preclinical immunotherapy R&D services using its proprietary microfluidic platform, today announced that Neelima KC, Founder of Avigen Ltd. has been awarded a…